A Phase II Study of AZD4877 (a Novel Anti-mitotic Agent) in Advanced Bladder Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Gary Hudes, MD
Fox Chase Cancer Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
36 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Research Site
Vancouver, British Columbia, Canada
- Research Site
Halifax, Nova Scotia, Canada
- Research Site
Toronto, Ontario, Canada
- Research Site
Montreal, Quebec, Canada
- Research Site
Québec, Quebec, Canada
- Research Site
Berlin, Germany
- Research Site
Dresden, Germany
- Research Site
Düsseldorf, Germany
- Research Site
München, Germany
- Research Site
Münster, Germany
- Research Site
Barcelona, Spain
- Research Site
Madrid, Spain
- Research Site
Leeds, West Yorkshire, United Kingdom
- Research Site
Glasgow, United Kingdom
- Research Site
London, United Kingdom
- Research Site
Manchester, United Kingdom
- Research Site
Southampton, United Kingdom
- Research Site
Surrey, United Kingdom
- Research Site
Palo Alto, California, United States
- Research Site
San Bernardino, California, United States
- Research Site
Southington, Connecticut, United States
- Research Site
Miami, Florida, United States
- Research Site
Atlanta, Georgia, United States
- Research Site
Marietta, Georgia, United States
- Research Site
Chicago, Illinois, United States
- Research Site
Scarborough, Maine, United States
- Research Site
Ann Arbor, Michigan, United States
- Research Site
Minneapolis, Minnesota, United States
- Research Site
Hackensack, New Jersey, United States
- Research Site
Morristown, New Jersey, United States
- Research Site
New York, New York, United States
- Research Site
Charlotte, North Carolina, United States
- Research Site
Philadelphia, Pennsylvania, United States
- Research Site
Woonsocket, Rhode Island, United States
- Research Site
Seattle, Washington, United States
- Research Site
Morgantown, West Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 May 2008
- Primary completion
- 31 May 2009
- Completion
- 31 Dec 2009
- Last update posted
- 12 Jan 2011
- Registered enrollment
- 54
- Registry id
- NCT00661609
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.